Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop

Immunity

Volumn 11, Issue 2, 1999, Pages 191-200

  Fujimoto, Manabu ^a   Bradney, Alice P ^a   Poe, Jonathan C ^a   Steeber, Douglas A ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD22 ANTIGEN; IMMUNOGLOBULIN M; LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; FLOW CYTOMETRY; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0033179893     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80094-1     Document Type: Article

References (58)

1. Buhl, A.M., and Cambier, J.C. (1999). Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162, 4438-4446.
2. 2+ mobilization. J. Exp. Med. 186, 1897-1910.
3. Carroll, M.C. (1998). CD21/CD35 in B cell activation. Semin. Immunol. 10, 279-286.
4. Carter, R.H., Doody, G.M., Bolen, J.B., and Fearon, D.T. (1997). Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J. Immunol. 158, 3062-3069.
5. Chalupny, N.J., Kanner, S.B., Schieven, G.L., Wee, S., Gilliland, L.K., Aruffo, A., and Ledbetter, J.A. (1993). Tyrosine phosphorylation of CD19 in pre-B and mature B cells. EMBO J. 12, 2691-2696.
6. Chan, V.W.F., Meng, F., Soriano, P., DeFranco, A.L., and Lowell, C.A. (1997). Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7, 69-81.
7. Chan, V.W.F., Lowell, C.A., and DeFranco, A.L. (1998). Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8, 545-553.
8. Cornall, R.J., Cyster, J.G., Hibbs, M.L., Dunn, A.R., Otipoby, K.L., Clark, E.A., and Goodnow, C.C. (1998). Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8, 497-508.
9. Cyster, J.G., and Goodnow, C.C. (1995). Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24.
10. Cyster, J.G., and Goodnow, C.C. (1997). Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment. Immunity 6, 509-517.
11. DeFranco, A.L., Chan, V.W.F., and Lowell, C.A. (1998). Positive and negative roles of the tyrosine kinase lyn in B cell function. Semin. Immunol. 10, 299-308.
12. Doody, G.M., Justement, L.B., Delibrias, C.C., Mathews, R.J., Lin, J., Thomas, M.L., and Fearon, D.T. (1995). A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269, 242-244.
13. Engel, P., Nojima, Y., Rothstein, D., Zhou, L.-J., Wilson, G.L., Kehrl, J.H., and Tedder, T.F. (1993). The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes. J. Immunol. 150, 4719-4732.
14. Engel, P., Zhou, L.-J., Ord, D.C., Sato, S., Koller, B., and Tedder, T.F. (1995). Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3, 39-50.
15. Fujimoto, M., Poe, J.C., Inaoki, M., and Tedder, T.F. (1998). CD19 regulates B lymphocyte responses to transmembrane signals. Semin. Immunol. 10, 267-277.
16. Fujimoto, M., Poe, J.C., Jansen, P.J., Sato, S., and Tedder, T.F. (1999). CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162, 7088-7094.
17. Healy, J.I., and Goodnow, C.C. (1998). Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16, 645-670.
18. Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S.A., and Dunn, A.R. (1995). Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311.
19. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7, 49-58.
20. Inaoki, M., Sato, S., Weintraub, B.C., Goodnow, C.C., and Tedder, T.F. (1997). CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186, 1923-1931.
21. Kelm, S., Pelz, A., Schauer, R., Filbin, M.T., Tang, S., de Bellard, M.-E., Schnaar, R.L., Mahoney, J.A., Hartnell, A., Bradfield, P., et al. (1994). Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 4, 965-972.
22. Kozlowski, M., Mlinaric-Rascan, I., Feng, G.S., Shen, R., Pawson, T., and Siminovitch, K.A. (1993). Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178, 2157-2163.
23. Krop, I., Shaffer, A.L., Fearon, D.T., and Schlissel, M.S. (1996). The signaling activity of murine CD19 is regulated during B cell development. J. Immunol. 157, 48-56.
24. Lankester, A.C., van Schijndel, G.M., and van Lier, R.A. (1995). Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligation. J. Biol. Chem. 270, 20305-20308.
25. Law, C.-L., Sidorenko, S.P., Chandran, K.A., Zhao, Z., Shen, S.-H., Fischer, E.H., and Clark, E.A. (1996). CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B cell activation. J. Exp. Med. 183, 547-560.
26. Leprince, C., Draves, K.E., Geahlen, R.L., Ledbetter, J.A., and Clark, E.A. (1993). CD22 associates with the human surface IgM-B cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 90,3236-3240.
27. Li, X., Sandoval, D., Freeberg, L., and Carter, R.H. (1997). Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J. Immunol. 158, 5649-5657.
28. Lorenz, U., Ravichandran, K.S., Burakoff, S.J., and Neel, B.G. (1996). Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc. Natl. Acad. Sci. USA 93, 9624-9629.
29. Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, T., and Yamamoto, T. (1995). Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3, 549-560.
30. Nishizumi, H., Horikawa, K., Mlinaric-Rascan, I., and Yamamoto, T. (1998). A double-edged kinase Lyn: A positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187,1343-1348.
31. Nitschke, L., Carsetti, R., Ocker, B., Kohler, G., and Lamers, M.C. (1997). CD22 is a negative regulator of B-cell receptor signaling. Curr. Biol. 7, 133-143.
32. O'Keefe, T.L., Williams, G.T., Davies, S.L., and Neuberger, M.S. (1996). Hyperresponsive B cells in CD22-deficient mice. Science 274, 798-801.
33. O'Keefe, T.L., Williams, G.T., Batista, F.D., and Neuberger, M.S. (1999). Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189, 1307-1313.
34. O'Rourke, L.M., Tooze, R., Turner, M., Sandoval, D.M., Carter, R.H., Tybulewicz, V.L.J., and Fearon, D.T. (1998). CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of vav. Immunity 8, 635-645.
35. Otipoby, K.L., Andersson, K.B., Draves, K.E., Klaus, S.J., Farr, A.G., Kerner, J.D., Perlmutter, R.M., Law, C.-L., and Clark, E.A. (1996). CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384, 634-637.
36. Pani, G., Siminovitch, K.A., and Paige, C.J. (1997). The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J. Exp. Med. 186, 581-588.
37. Peaker, C.J.G., and Neuberger, M.S. (1993). Association of CD22 with the B cell antigen receptor. Eur. J. Immunol. 23, 1358-1363.
38. Rickert, R.C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352-355.
39. Sato, S., Steeber, D.A., and Tedder, T.F. (1995). The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92, 11558-11562.
40. Sato, S., Miller, A.S., Inaoki, M., Bock, C.B., Jansen, P.J., Tang, M.L.K., and Tedder, T.F. (1996a). CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 5, 551-562.
41. Sato, S., Ono, N., Steeber, D.A., Pisetsky, D.S., and Tedder, T.F. (1996b). CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157, 4371-4378.
42. Sato, S., Jansen, P.J., and Tedder, T.F. (1997a). CD19 and CD22 reciprocally regulate Vav tyrosine phosphorylation during B lymphocyte signaling. Proc. Natl. Acad. Sci. USA 94, 13158-13162.
43. Sato, S., Steeber, D.A., Jansen, P.J., and Tedder, T.F. (1997b). CD19 expression levels regulate B lymphocyte development: Human CD19 restores normal function in mice lacking endogenous CD19. J. ImMunol. 158, 4662-4669.
44. Sato, S., Tuscano, J.M., Inaoki, M., and Tedder, T.F. (1998). CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin. Immunol. 10, 287-297.
45. Schulte, R.J., Campbell, M.A., Fischer, W.H., and Sefton, B.M. (1992). Tyrosine phosphorylation of CD22 during B cell activation. Science 258, 1001-1004.
46. Siminovitch, K.A., and Neel, B.G. (1998). Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases. Semin. Immunol. 10, 329-347.
47. Smith, K.G.C., Tarlinton, D.M., Doody, G.M., Hibbs, M.L., and Fearon, D.T. (1998). Inhibition of the B cell by CD22: A requirement for Lyn. J. Exp. Med. 187, 807-811.
48. Tedder, T.F. (1998). Response-regulators of B lymphocyte signaling thresholds provide a context for antigen receptor signal transduction. Semin. Immunol. 10, 259-265.
49. Tedder, T.F., and Isaacs, C.M. (1989). Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: A new member of the immunoglobulin superfamily. J. Immunol. 143, 712-717.
50. Tedder, T.F., Inaoki, M., and Sato, S. (1997a). The CD19/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6, 107-118.
51. Tedder, T.F., Tuscano, J., Sato, S., and Kehrl, J.H. (1997b). CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 15, 481-504.
52. Tooze, R.M., Doody, G.M., and Fearon, D.T. (1997). Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7, 59-67.
53. Tuscano, J.M., Engel, P., Tedder, T.F., Agarwal, A., and Kehrl, J.H. (1996). Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur. J. Immunol. 26, 1246-1252.
54. Tuveson, D.A., Carter, R.H., Soltoff, S.P., and Fearon, D.T. (1993). CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260, 986-989.
55. Uckun, F.M., Burkhardt, A.L., Jarvis, L., Jun, X., Stealey, B., Dibirdik, I., Myers, D.E., Tuel-Ahlgren, L., and Bolen, J.B. (1993). Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 268, 21172-21184.
56. Weng, W.K., Jarvis, L., and Lebien, T.W. (1994). Signaling through CD19 activates vav/mitogen-activated protein kinase pathway and induces formation of a CD19/vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269, 32514-32521.
57. Wilson, G.L., Fox, C.H., Fauci, A.S., and Kehrl, J.H. (1991). CDNA cloning of the B cell membrane protein CD22: A mediator of B-B cell interactions. J. Exp. Med. 173, 137-146.
58. Zhou, L.-J., Smith, H.M., Waldschmidt, T.J., Schwarting, R., Daley, J., and Tedder, T.F. (1994). Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development. Mol. Cell. Biol. 14, 3884-3894.